140 related articles for article (PubMed ID: 3107804)
41. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine melanoma cells prolong the survival of mice with melanoma.
Kim TS; Cohen EP
Cancer Res; 1994 May; 54(10):2531-5. PubMed ID: 8168073
[TBL] [Abstract][Full Text] [Related]
42. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
43. Clonal variation in tumorigenicity of L1210 lymphoma cells: nontumorigenic variants with an enhanced expression of tumor-associated antigen and Ia antigens.
Fuji H; Iribe H
Cancer Res; 1986 Nov; 46(11):5541-7. PubMed ID: 3489524
[TBL] [Abstract][Full Text] [Related]
44. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
[TBL] [Abstract][Full Text] [Related]
45. Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene.
Plaksin D; Gelber C; Feldman M; Eisenbach L
Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4463-7. PubMed ID: 3380801
[TBL] [Abstract][Full Text] [Related]
46. IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells.
Ferrantini M; Giovarelli M; Modesti A; Musiani P; Modica A; Venditti M; Peretti E; Lollini PL; Nanni P; Forni G
J Immunol; 1994 Nov; 153(10):4604-15. PubMed ID: 7963533
[TBL] [Abstract][Full Text] [Related]
47. Differences in expression of MHC products between several H-2-restricted CTL clones.
Hauptfeld V; Braciale TJ; Shreffler DC
J Immunol; 1982 May; 128(5):2026-31. PubMed ID: 6977581
[TBL] [Abstract][Full Text] [Related]
48. The c-fos proto-oncogene in murine 3LL carcinoma clones controls the expression of MHC genes.
Kushtai G; Barzilay J; Feldman M; Eisenbach L
Oncogene; 1988 Feb; 2(2):119-27. PubMed ID: 2453011
[TBL] [Abstract][Full Text] [Related]
49. Tumor-specific immunity induced by somatic hybrids. I. Lack of relationship between immunogenicity and tumorigenicity of selected hybrids.
Kim BS; Liang W; Cohen EP
J Immunol; 1979 Aug; 123(2):733-8. PubMed ID: 88482
[TBL] [Abstract][Full Text] [Related]
50. Suppression of anchorage-independent growth of human glioblastoma cell by major histocompatibility complex class I gene-transfection.
Momozaki N; Oh-Uchida M; Tabuchi K; Ikezaki K; Hori K
J Neurosurg; 1992 May; 76(5):845-9. PubMed ID: 1564545
[TBL] [Abstract][Full Text] [Related]
51. [Immunological responsiveness in C57BL/6 mice during the growth of a tumoural graft: the Lewis' lung carcinoma (author's transl)].
Milon G; Fauve RM
Ann Immunol (Paris); 1976; 127(5):675-85. PubMed ID: 825018
[TBL] [Abstract][Full Text] [Related]
52. Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection.
Bahler DW; Frelinger JG; Harwell LW; Lord EM
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4562-6. PubMed ID: 3496596
[TBL] [Abstract][Full Text] [Related]
53. c-fos transfection of 3LL tumor cells turns on MHC gene expression and consequently reduces their metastatic competence.
Kushtai G; Feldman M; Eisenbach L
Int J Cancer; 1990 Jun; 45(6):1131-6. PubMed ID: 2351488
[TBL] [Abstract][Full Text] [Related]
54. The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells.
Eisenbach L; Hollander N; Greenfeld L; Yakor H; Segal S; Feldman M
Int J Cancer; 1984 Oct; 34(4):567-73. PubMed ID: 6490207
[TBL] [Abstract][Full Text] [Related]
55. Effect of MHC class-I transfection on local tumor growth and metastasis in an H-2-negative clone derived from a chemically induced fibrosarcoma.
Mialdea MJ; Martin J; Gaforio JJ; Algarra I; Pérez M; Gonzalez A; Ljunggren HG; Garrido F
Int J Cancer; 1992 Aug; 52(1):153-8. PubMed ID: 1500219
[TBL] [Abstract][Full Text] [Related]
56. Altered growth of a human neuroendocrine carcinoma line after transfection of a major histocompatibility complex class I gene.
Sunday ME; Isselbacher KJ; Gattoni-Celli S; Willett CG
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4700-4. PubMed ID: 2660144
[TBL] [Abstract][Full Text] [Related]
57. Stimulation of tumor cell growth in vitro by a monoclonal antibody to a tumor specific protein (TSP-180) present on the cell surface of 3LL cells.
Sacchi A; Piaggio G; Rizzo MA; Falcioni R; Kennel SJ
Clin Exp Metastasis; 1989; 7(1):41-54. PubMed ID: 2783240
[TBL] [Abstract][Full Text] [Related]
58. Driving adenovirus type 12-transformed BALB/c mouse cells to express high levels of class I major histocompatibility complex proteins enhances, rather than abrogates, their tumorigenicity.
Soddu S; Lewis AM
J Virol; 1992 May; 66(5):2875-84. PubMed ID: 1313906
[TBL] [Abstract][Full Text] [Related]
59. Expression of ganglioside GM3 and H-2 antigens in clones with different metastatic and growth potentials isolated from Lewis lung carcinoma (3LL) cell line.
Inokuchi J; Jimbo M; Kumamoto Y; Shimeno H; Nagamatsu A
Clin Exp Metastasis; 1993 Jan; 11(1):27-36. PubMed ID: 8422703
[TBL] [Abstract][Full Text] [Related]
60. Structure and expression of a mouse major histocompatibility antigen gene, H-2Ld.
Evans GA; Margulies DH; Camerini-Otero RD; Ozato K; Seidman JG
Proc Natl Acad Sci U S A; 1982 Mar; 79(6):1994-8. PubMed ID: 6952248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
